ANNI 2008-2013
142. Guidelli GM, Martellucci I, Galeazzi M, Francini G, Fioravanti A. Sjögren's syndrome and
aromatase inhibitors treatment: is there a link? Clin Exp Rheumatol. 2013 Apr 3.
141. Adinolfi A, Picerno V, Di Sabatino V, Bertoldi I, Galeazzi M, Frediani B, Filippou G.Inquiry
is fatal to certainty: Is the US double contour sign specific for uric acid arthritis? Arthritis Rheum.
2013 Apr 1. doi: 10.1002/art.37952.
140. Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S, Barreca C,
Galeazzi M, Laghi-Pasini F.Association between high sensitivity C-reactive protein, heart rate
variability and corrected QT interval in patients with chronic inflammatory arthritis.Eur J Intern
Med. 2013 Mar 18.
139. Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, Kamen DL, Gilkeson
GS, Jacob CO, Scofield RH, Langefeld CD, Kelly JA, Ramsey-Goldman R, Petri MA, Reveille JD,
Vilá LM, Alarcón GS, Vyse TJ, Pons-Estel BA; Argentine Collaborative Group, Freedman BI,
Gaffney PM, Sivils KM, James JA, Gregersen PK, Anaya JM, Niewold TB, Merrill JT, Criswell
LA, Stevens AM, Boackle SA, Cantor RM, Chen W, Grossman JM, Hahn BH, Harley JB, AlarcόnRiquelme ME; BIOLUPUS and GENLES networks, Brown EE, Tsao BP. MicroRNA-3148
modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus
erythematosus. PLoS Genet. 2013;9(2):e1003336.
138. De Nardo P, Bellagamba R, Corpolongo A, Gentilotti E, Taglietti F, Rosati S, Galeazzi M,
Sebastiani GD, Quinti I, Nicastri E. Septic Shock after Seasonal Influenza Vaccination in an HIVInfected Patient during Treatment with Etanercept for Rheumatoid Arthritis: a Case Report. Clin
Vaccine Immunol. 2013 May;20(5):761-4.
137. Filippou G, Di Sabatino V, Adinolfi A, Bertoldi I, Picerno V, Biasi G, Galeazzi M, Frediani B
No enthesis should be overlooked when psoriatic arthritis is suspected: enthesitis of the extensor
digitorum tendons. J Rheumatol. 2013 Mar;40(3):335. doi: 10.3899/jrheum.121123. No abstract
available.
136. Frediani B, Bertoldi I, Pierguidi S, Nicosia A, Picerno V, Filippou G, Cantarini L, Galeazzi M.
Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice
weekly) compared with 100 mg (once weekly) for increasing bone mineral density in
postmenopausal osteoporosis. Clin Drug Investig. 2013 Mar;33(3):193-8.
136. Clin Exp Rheumatol. 2013 May-Jun;31(3):341-349. Epub 2013 Feb 1.
135. Galeazzi M, Frezzotti A, Paladini C, Leoni P, Tocchini M . A case of monoclonal gammopathy
of undetermined significance (MGUS): type IgD-lambda.Clin Chem Lab Med. 2012 Jan 10:1-3.
doi: 10.1515/cclm-2012-0687. [Epub ahead of print] No abstract available.
1: Ceccarelli F, Perricone C, Trotta F, Cuomo G, Pellerito R, Bagnato G, Salaffi
F, Caporali R, Cutolo M, Galeazzi M, Fiocco U, Lapadula G, Bombardieri S, Bianchi
G, Gorla R, Giardina AR, Gallo G, Giardino AM, Valesini G, On Behalf Of The Arpa
Study Group 1. Remission in early, aggressive rheumatoid arthritis: a multicentre
prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva). Clin Exp
Rheumatol. 2013 May-Jun;31(3):341-349.
2: Fioravanti A, Tenti S, Giannitti C, Fortunati NA, Galeazzi M. Short- and
long-term effects of mud-bath treatment on hand osteoarthritis: a randomized
clinical trial. Int J Biometeorol. 2013 Jan 14.
3: Cantarini L, Brucato A, Simonini G, Imazio M, Cumetti D, Cimaz R, Bacarelli
MR, Muscari I, Vitale A, Lucherini OM, Galeazzi M, Fioravanti A. Leptin,
adiponectin, resistin, visfatin serum levels and idiopathic recurrent
pericarditis: biomarkers of disease activity? A preliminary report. Clin Exp
Rheumatol. 2012 Nov 8.
4: Giordano N, Volpi N, Franci D, Corallo C, Fioravanti A, Papakostas P, Montella
A, Biagioli M, Fimiani M, Grasso G, Muscettola MM, Guerranti R, Vannoni D,
Galeazzi M, Nuti R. Expression of RXFP1 in skin of scleroderma patients and
control subjects. Scand J Rheumatol. 2012 Oct;41(5):391-5.
5: Lazzerini PE, Capperucci C, Spreafico A, Capecchi PL, Niccolini S, Ferrata P,
Frediani B, Galeazzi M, Laghi-Pasini F. Rosuvastatin inhibits spontaneous and
IL-1β-induced interleukin-6 production from human cultured osteoblastic cells.
Joint Bone Spine. 2012 Sep 19.
6: Ceccarelli F, D'Alfonso S, Perricone C, Carlomagno Y, Alessandri C, Croia C,
Barizzone N, Montecucco C, Galeazzi M, Sebastiani GD, Minisola G, Fiocco U,
Valesini G. The role of eight polymorphisms in three candidate genes in
determining the susceptibility, phenotype, and response to anti-TNF therapy in
patients with rheumatoid arthritis. Clin Exp Rheumatol. 2012
Nov-Dec;30(6):939-42.
7: Vitale A, Lucherini OM, Galeazzi M, Frediani B, Cantarini L. Long-term
clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case
series. Clin Exp Rheumatol. 2012 Nov-Dec;30(6):943-6.
8: Cantarini L, Obici L, Simonini G, Cimaz R, Bacarelli MR, Merlini G, Vitale A,
Lucherini OM, Brizi MG, Galeazzi M, Fioravanti A. Serum leptin, resistin,
visfatin and adiponectin levels in tumor necrosis factor receptor-associated
periodic syndrome (TRAPS). Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl
72):S108-14.
9: Cantarini L, Vitale A, Galeazzi M, Frediani B. A case of resistant
adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical
adenitis (PFAPA) syndrome responsive to anakinra. Clin Exp Rheumatol. 2012
Jul-Aug;30(4):593.
10: Manganelli S, Rossi M, Tuccori M, Galeazzi M. Guillain-Barré syndrome
following adalimumab treatment. Clin Exp Rheumatol. 2012 Jul-Aug;30(4):592. Epub
2012 Aug 29.
11: Reggia R, Ziglioli T, Andreoli L, Bellisai F, Iuliano A, Gerosa M, Ramoni V,
Tani C, Brucato A, Galeazzi M, Mosca M, Caporali R, Meroni PL, Tincani A. Primary
anti-phospholipid syndrome: any role for serum complement levels in predicting
pregnancy complications? Rheumatology (Oxford). 2012 Dec;51(12):2186-90.
12: Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG,
Simonini G, Cimaz R. Tumour necrosis factor receptor-associated periodic syndrome
(TRAPS): state of the art and future perspectives. Autoimmun Rev. 2012
Nov;12(1):38-43.
13: Fioravanti A, Tinti L, Pascarelli NA, Di Capua A, Lamboglia A, Cappelli A,
Biava M, Giordani A, Niccolini S, Galeazzi M, Anzini M. In vitro effects of
VA441, a new selective cyclooxygenase-2 inhibitor, on human osteoarthritic
chondrocytes exposed to IL-1β. J Pharmacol Sci. 2012;120(1):6-14.
14: Muscari I, Iacoponi F, Cantarini L, Lucherini OM, Simonini G, Brizi MG,
Vitale A, Frediani B, Cimaz R, Galeazzi M. The diagnostic evaluation of patients
with potential adult-onset autoinflammatory disorders: our experience and review
of the literature. Autoimmun Rev. 2012 Nov;12(1):10-3.
15: Cantarini L, Giani T, Fioravanti A, Iacoponi F, Simonini G, Pagnini I,
Spreafico A, Chellini F, Galeazzi M, Cimaz R. Serum amyloid A circulating levels
and disease activity in patients with juvenile idiopathic arthritis. Yonsei Med
J. 2012 Sep;53(5):1045-8.
16: Millucci L, Spreafico A, Tinti L, Braconi D, Ghezzi L, Paccagnini E,
Bernardini G, Amato L, Laschi M, Selvi E, Galeazzi M, Mannoni A, Benucci M,
Lupetti P, Chellini F, Orlandini M, Santucci A. Alkaptonuria is a novel human
secondary amyloidogenic disease. Biochim Biophys Acta. 2012 Nov;1822(11):1682-91.
17: Atzeni F, Sarzi-Puttini P, Botsios C, Carletto A, Cipriani P, Favalli EG,
Frati E, Foschi V, Gasparini S, Giardina A, Gremese E, Iannone F, Sebastiani M,
Ziglioli T, Biasi D, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Gorla R, Govoni
M, Lapadula G, Marchesoni A, Salaffi F, Punzi L, Triolo G, Ferraccioli G.
Long-term anti-TNF therapy and the risk of serious infections in a cohort of
patients with rheumatoid arthritis: comparison of adalimumab, etanercept and
infliximab in the GISEA registry. Autoimmun Rev. 2012 Dec;12(2):225-9.
.18: Cantarini L, Vitale A, Borri M, Galeazzi M, Franceschini R. Successful use of
canakinumab in a patient with resistant Behçet's disease. Clin Exp Rheumatol.
2012 May-Jun;30(3 Suppl 72):S115.
19: Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina AR, Favalli
EG, Erre GL, Gorla R, Galeazzi M, Foti R, Cantini F, Salvarani C, Olivieri I,
Lapadula G, Ferraccioli G; Gruppo Italiano di Studio sulle Early Arthritis
(GISEA). Obesity and reduction of the response rate to anti-tumor necrosis factor
α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care
Res (Hoboken). 2013 Jan;65(1):94-100.
20: Brizi MG, Galeazzi M, Lucherini OM, Cantarini L, Cimaz R. Successful
treatment of tumor necrosis factor receptor-associated periodic syndrome with
canakinumab. Ann Intern Med. 2012 Jun 19;156(12):907-8.
21: Meini S, Cucchi P, Tinti L, Niccolini S, Bellucci F, Catalani C, Valenti C,
Galeazzi M, Fioravanti A, Maggi CA. Fasitibant prevents the bradykinin and
interleukin 1β synergism on prostaglandin E₂ release and cyclooxygenase 2
expression in human fibroblast-like synoviocytes. Naunyn Schmiedebergs Arch
Pharmacol. 2012 Aug;385(8):777-86.
22: Gonzalez EG, Selvi E, Balistreri E, Akhmetshina A, Palumbo K, Lorenzini S,
Lazzerini PE, Montilli C, Capecchi PL, Lucattelli M, Baldi C, Gianchecchi E,
Galeazzi M, Pasini FL, Distler JH. Synthetic cannabinoid ajulemic acid exerts
potent antifibrotic effects in experimental models of systemic sclerosis. Ann
Rheum Dis. 2012 Sep;71(9):1545-51.
23: Galeazzi M, Balistreri E, Giannitti C, Sebastiani GD. MicroRNAs in autoimmune
rheumatic diseases. Reumatismo. 2012 Mar 16;64(1):7-17. doi:
10.4081/reumatismo.2012.7.
24: Iannone F, Gremese E, Atzeni F, Biasi D, Botsios C, Cipriani P, Ferri C,
Foschi V, Galeazzi M, Gerli R, Giardina A, Marchesoni A, Salaffi F, Ziglioli T,
Lapadula G; Gruppo Italiano di Studio sulle Early Arthritides (GISEA). Longterm
retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort
of patients with rheumatoid arthritis from the GISEA registry: an appraisal of
predictors. J Rheumatol. 2012 Jun;39(6):1179-84.
25: Filippou G, Bozios P, Gambera D, Lorenzini S, Bertoldi I, Adinolfi A,
Galeazzi M, Frediani B. Ultrasound detection of calcium pyrophosphate dihydrate
crystal deposits in menisci: a pilot in vivo and ex vivo study. Ann Rheum Dis.
2012 Aug;71(8):1426-7. doi: 10.1136/annrheumdis-2011-201001.
26: Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria
A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia
M, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni
(FIRMA) investigators. Diagnostic value of anti-mutated citrullinated vimentin in
comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated
peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and
review of the literature. Autoimmun Rev. 2012 Sep;11(11):815-20.
27: Cantarini L, Vitale A, Bartolomei B, Galeazzi M, Rigante D. Diagnosis of
PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent
fevers. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):269-71.
28: Cantarini L, Lucherini OM, Brucato A, Barone L, Cumetti D, Iacoponi F,
Rigante D, Brambilla G, Penco S, Brizi MG, Patrosso MC, Valesini G, Frediani B,
Galeazzi M, Cimaz R, Paolazzi G, Vitale A, Imazio M. Clues to detect tumor
necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with
idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res
Cardiol. 2012 Jul;101(7):525-31.
29: Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, Zultak
M, Matucci-Cerinic M; DUO Registry investigators. Demographic, clinical and
antibody characteristics of patients with digital ulcers in systemic sclerosis:
data from the DUO Registry. Ann Rheum Dis. 2012 May;71(5):718-21.
30: Gandini F, Giannitti C, Fattore G, Giordano N, Galeazzi M, Fioravanti A.
Validation of an Italian version of the functional index for hand osteoarthritis
(FIHOA). Mod Rheumatol. 2012 Sep;22(5):758-65.
31: Cantarini L, Lucherini OM, Frediani B, Brizi MG, Bartolomei B, Cimaz R,
Galeazzi M, Rigante D. Bridging the gap between the clinician and the patient
with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol. 2011
Oct-Dec;24(4):827-36.
32: Taraborelli M, Ramoni V, Brucato A, Airò P, Bajocchi G, Bellisai F, Biasi D,
Blagojevic J, Canti V, Caporali R, Caramaschi P, Chiarolanza I, Codullo V, Cozzi
F, Cuomo G, Cutolo M, De Santis M, De Vita S, Di Poi E, Doria A, Faggioli P,
Favaro M, Ferraccioli G, Ferri C, Foti R, Gerosa A, Gerosa M, Giacuzzo S, Giani
L, Giuggioli D, Imazio M, Iudici M, Iuliano A, Leonardi R, Limonta M, Lojacono A,
Lubatti C, Matucci-Cerinic M, Mazzone A, Meroni M, Meroni PL, Mosca M, Motta M,
Muscarà M, Nava S, Padovan M, Pagani G, Paolazzi G, Peccatori S, Ravagnani V,
Riccieri V, Rosato E, Rovere-Querini P, Salsano F, Santaniello A, Scorza R, Tani
C, Valentini G, Valesini G, Vanoli M, Vigone B, Zeni S, Tincani A; IMPRESS
Investigators. Brief report: successful pregnancies but a higher risk of preterm
births in patients with systemic sclerosis: an Italian multicenter study.
Arthritis Rheum. 2012 Jun;64(6):1970-7.
33: Hughes T, Adler A, Merrill JT, Kelly JA, Kaufman KM, Williams A, Langefeld
CD, Gilkeson GS, Sanchez E, Martin J, Boackle SA, Stevens AM, Alarcón GS, Niewold
TB, Brown EE, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD,
Criswell LA, Vilá LM, Jacob CO, Gaffney PM, Moser KL, Vyse TJ, Alarcón-Riquelme
ME; BIOLUPUS Network, James JA, Tsao BP, Scofield RH, Harley JB, Richardson BC,
Sawalha AH. Analysis of autosomal genes reveals gene-sex interactions and higher
total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis. 2012
May;71(5):694-9.
34: Cantarini L, Simonini G, Frediani B, Pagnini I, Galeazzi M, Cimaz R.
Treatment strategies for childhood noninfectious chronic uveitis: an update.
Expert Opin Investig Drugs. 2012 Jan;21(1):1-6.
35: Lazzerini PE, Natale M, Gianchecchi E, Capecchi PL, Montilli C, Zimbone S,
Castrichini M, Balistreri E, Ricci G, Selvi E, Garcia-Gonzalez E, Galeazzi M,
Laghi-Pasini F. Adenosine A2A receptor activation stimulates collagen production
in sclerodermic dermal fibroblasts either directly and through a cross-talk with
the cannabinoid system. J Mol Med (Berl). 2012 Mar;90(3):331-42.
36: Cantarini L, Simonini G, Fioravanti A, Generoso M, Bacarelli MR, Dini E,
Galeazzi M, Cimaz R. Circulating levels of the adipokines vaspin and omentin in
patients with juvenile idiopathic arthritis, and relation to disease activity.
Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1044-8.
37: Sebastiani GD, Fulci V, Niccolini S, Giannitti C, Bugatti S, Minisola G,
Barnaba V, Scappucci G, Macino G, Galeazzi M. Over-expression of miR-223 in
T-lymphocytes of early rheumatoid arthritis patients. Clin Exp Rheumatol. 2011
Nov-Dec;29(6):1058-9.
38: Cantarini L, Iacoponi F, Lucherini OM, Obici L, Brizi MG, Cimaz R, Rigante D,
Benucci M, Sebastiani GD, Brucato A, Sabadini L, Simonini G, Giani T, Laghi
Pasini F, Baldari CT, Bellisai F, Valentini G, Bombardieri S, Paolazzi G,
Galeazzi M. Validation of a diagnostic score for the diagnosis of
autoinflammatory diseases in adults. Int J Immunopathol Pharmacol. 2011
Jul-Sep;24(3):695-702.
39: Cantarini L, Rigante D, Brizi MG, Lucherini OM, Sebastiani GD, Vitale A,
Gianneramo V, Galeazzi M. Clinical and biochemical landmarks in systemic
autoinflammatory diseases. Ann Med. 2012 Nov;44(7):664-73.
40: Lazzerini PE, Capecchi PL, Laghi-Pasini F, Galeazzi M. Comment on: letter to
the editor from Clockaerts and Bierma-Zeinstra. Semin Arthritis Rheum. 2011
Oct;41(2):e3-4.
41: Tinti L, Spreafico A, Chellini F, Galeazzi M, Santucci A. A novel ex vivo
organotypic culture model of alkaptonuria-ochronosis. Clin Exp Rheumatol. 2011
Jul-Aug;29(4):693-6.
42: Cantarini L, Rigante D, Brizi MG, Sebastiani GD, Lucherini OM, Galeazzi M,
Frediani B. [The laboratory approach in the diagnosis of systemic
autoinflammatory diseases]. Reumatismo. 2011;63(2):101-10. Review. Italian.
43: Lazzerini PE, Capecchi PL, Acampa M, Morozzi G, Bellisai F, Bacarelli MR,
Dragoni S, Fineschi I, Simpatico A, Galeazzi M, Laghi-Pasini F.
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of
antibody level and specificity. Arthritis Care Res (Hoboken). 2011
Oct;63(10):1463-70.
44: Torricelli M, Bellisai F, Novembri R, Galeazzi LR, Iuliano A, Voltolini C,
Spreafico A, Galeazzi M, Petraglia F. High levels of maternal serum IL-17 and
activin A in pregnant women affected by systemic lupus erythematosus. Am J Reprod
Immunol. 2011 Aug;66(2):84-9.
45: Fioravanti A, Giannitti C, Bellisai B, Iacoponi F, Galeazzi M. Efficacy of
balneotherapy on pain, function and quality of life in patients with
osteoarthritis of the knee. Int J Biometeorol. 2012 Jul;56(4):583-90. doi:
10.1007/s00484-011-0447-0.
46: Fioravanti A, Bellisai B, Iacoponi F, Manica P, Galeazzi M.
Phytothermotherapy in osteoarthritis: a randomized controlled clinical trial. J
Altern Complement Med. 2011 May;17(5):407-12.
47: Bellisai F, Morozzi G, Scaccia F, Chellini F, Simpatico A, Pecetti G,
Galeazzi M. Evaluation of the effect of Bosentan treatment on proinflammatory
cytokine serum levels in patients affected by Systemic Sclerosis. Int J
Immunopathol Pharmacol. 2011 Jan-Mar;24(1):261-4.
48: Giannitti C, Sebastiani GD, Manganelli S, Galeazzi M. Safety of anti-tumor
necrosis factor agents in rheumatic potential carriers of occult hepatitis B
virus. J Rheumatol. 2011 Apr;38(4):780-1.
49: Fioravanti A, Simonini G, Cantarini L, Generoso M, Galeazzi M, Bacarelli MR,
Cimaz R. Circulating levels of the adipocytokines vaspin and omentin in patients
with Kawasaki disease. Rheumatol Int. 2012 May;32(5):1481-2.
50: Hughes T, Kim-Howard X, Kelly JA, Kaufman KM, Langefeld CD, Ziegler J,
Sanchez E, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Martín
J, Brown EE, Vilá LM, Alarcón GS, James JA, Gilkeson GS, Moser KL, Gaffney PM,
Merrill JT, Vyse TJ, Alarcón-Riquelme ME; BIOLUPUS Network, Nath SK, Harley JB,
Sawalha AH. Fine-mapping and transethnic genotyping establish IL2/IL21 genetic
association with lupus and localize this genetic effect to IL21. Arthritis Rheum.
2011 Jun;63(6):1689-97.
51: Filippou G, Cantarini L, Bertoldi I, Picerno V, Frediani B, Galeazzi M.
Ultrasonography vs. clinical examination in children with suspected arthritis.
Does it make sense to use poliarticular ultrasonographic screening? Clin Exp
Rheumatol. 2011 Mar-Apr;29(2):345-50.
52: Pandozi C, Ficili S, Galeazzi M, Lavalle C, Russo M, Pandozi A, Venditti F,
Pristipino C, Verbo B, Santini M. Propagation of the sinus impulse into the Koch
triangle and localization, timing, and origin of the multicomponent potentials
recorded in this area. Circ Arrhythm Electrophysiol. 2011 Apr;4(2):225-34.
53.L'utilità di diagnostica di studi di conduzione del nervo rispetto ecografia in lieve
sindrome del tunnel carpale. Mondelli M, Filippou G, Gallo A, B Frediani .
Artrite Rheum . Mar 2008 15, 59 (3) :357-66. doi: 10.1002/art.23317. Recensione.
54: Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu
A, Meroni PL, Pregnolato F, Migliorini P, Radice A, Riccieri V, Ruffatti A,
Sebastiani GD, Sinico RA, Tincani A, Doria A; Forum Interdisciplinare per la
Ricerca sulle Malattie Autoimmuni(FIRMA) study group. Diagnostic accuracy of
currently available anti-double-stranded DNA antibody assays. An Italian
multicentre study. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):50-6.
55: Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F,
D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta
MA, Ines L, Duarte C, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten
G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman GM, Szmyrka-Kaczmarek M, Tani
C, Tincani A, Tzioufas AG, Voll R, Bencivelli W, Salaffi F, Bombardieri S. The
development of a simple questionnaire to screen patients with SLE for the
presence of neuropsychiatric symptoms in routine clinical practice. Lupus. 2011
Apr;20(5):485-92.
56: Antonini L, Ficili S, Pasceri V, Cianfrocca C, Galeazzi M, Pandozi C, Aiello
A, Santini M. A new echo-Doppler method to measure interatrial conduction time.
Validation and clinical usefulness. Minerva Cardioangiol. 2011 Feb;59(1):9-15.
57: Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M, Brizi
MG, Brucato A. Autoinflammatory diseases and cardiovascular manifestations. Ann
Med. 2011 Aug;43(5):341-6.
58: Cantarini L, Lucherini OM, Iacoponi F, Cimaz R, Simonini G, Rigante D, Laghi
Pasini F, Baldari CT, Capecchi PL, Brizi MG, Galeazzi M. Development and
preliminary validation of a diagnostic score for identifying patients affected
with adult-onset autoinflammatory disorders. Int J Immunopathol Pharmacol. 2010
Oct-Dec;23(4):1133-41.
59: Balistreri E, Garcia-Gonzalez E, Selvi E, Akhmetshina A, Palumbo K, Lorenzini
S, Maggio R, Lucattelli M, Galeazzi M, Distler JW. The cannabinoid WIN55, 212-2
abrogates dermal fibrosis in scleroderma bleomycin model. Ann Rheum Dis. 2011
Apr;70(4):695-9.
60: Cantarini L, Imazio M, Brizi MG, Lucherini OM, Brucato A, Cimaz R, Galeazzi
M. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic
recurrent pericarditis. Clin Rev Allergy Immunol. 2013 Feb;44(1):6-13. doi:
10.1007/s12016-010-8219-x.
61: Cantarini L, Capecchi PL, Lucherini OM, Laghi Pasini F, Galeazzi M. Familial
Mediterranean fever diagnosed in an elderly patient. Clin Exp Rheumatol. 2010
Jul-Aug;28(4 Suppl 60):S91. Epub 2010 Sep 24.
62: Fioravanti A, Cantarini L, Guidelli GM, Galeazzi M. Mechanisms of action of
spa therapies in rheumatic diseases: what scientific evidence is there? Rheumatol
Int. 2011 Jan;31(1):1-8.
63: Cantarini L, Lucherini OM, Cimaz R, Galeazzi M. Recurrent pericarditis caused
by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra
treatment. Clin Exp Rheumatol. 2010 Sep-Oct;28(5):802.
64: Pandozi C, Dottori S, Lavalle C, Ficili S, Galeazzi M, Russo M, Pandozi A,
Camastra G, Ansalone G, Santini M. Integration of MR images with
electroanatomical maps: feasibility and utility in guiding left ventricular
substrate mapping. J Interv Card Electrophysiol. 2010 Dec;29(3):157-66.
65.Cantarini L, Rigante D, Lucherini OM, Cimaz R, Laghi Pasini F, Baldari CT,
Benucci M, Simonini G, Di Sabatino V, Brizi MG, Galeazzi M. Role of etanercept in
the treatment of tumor necrosis factor receptor-associated periodic syndrome:
personal experience and review of the literature. Int J Immunopathol Pharmacol.
2010 Jul-Sep;23(3):701-7.
66: Lazzerini PE, Capecchi PL, Selvi E, Lorenzini S, Bisogno S, Baldari CT,
Galeazzi M, Laghi-Pasini F. Statins and the joint: multiple targets for a global
protection? Semin Arthritis Rheum. 2011 Apr;40(5):430-46.
67: Maggio R, Garcia-Gonzalez E, Selvi E, Bardelli M, Frati E, Galeazzi M. An
acutely swollen knee. BMJ. 2010 Sep 8;341:c4441.
68: Fioravanti A, Collodel G, Petraglia A, Nerucci F, Moretti E, Galeazzi M.
Effect of hydrostatic pressure of various magnitudes on osteoarthritic
chondrocytes exposed to IL-1beta. Indian J Med Res. 2010 Aug;132:209-17.
69: Gerlag DM, Hollis S, Layton M, Vencovský J, Szekanecz Z, Braddock M, Tak PP;
ESCAPE Study Group. Preclinical and clinical investigation of a CCR5 antagonist,
AZD5672, in patients with rheumatoid arthritis receiving methotrexate. Arthritis
Rheum. 2010 Nov;62(11):3154-60.
70: Cantarini L, Volpi N, Galeazzi M, Giani T, Fanti F, Lucherini OM, Aglianò M,
Alessandrini C, Giannini F, Magi S, Greco G, Baldari CT, Cimaz R. Colchicine
myopathy and neuromyopathy: two cases with different characteristics. J Clin
Rheumatol. 2010 Aug;16(5):229-32.
71: Selvi E, Garcia-Gonzalez E, Maggio R, Lorenzini S, Santucci A, Galeazzi M.
False proteinuria in patients with alkaptonuria. Clin Exp Rheumatol. 2010
Jul-Aug;28(4):591. 72: Tinti L, Spreafico A, Braconi D, Millucci L, Bernardini G, Chellini F,
Cavallo G, Selvi E, Galeazzi M, Marcolongo R, Gallagher JA, Santucci A.
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in
an in vitro human cell model. J Cell Physiol. 2010 Oct;225(1):84-91.
73: Simonini G, Cantarini L, Bresci C, Lorusso M, Galeazzi M, Cimaz R. Current
therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev.
2010 Aug;9(10):674-83.
74: Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M. Familial
clustering of recurrent pericarditis may disclose tumour necrosis factor
receptor-associated periodic syndrome. Clin Exp Rheumatol. 2010
May-Jun;28(3):405-7. 75: Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M.
Autoinflammatory disorders and patients with isolated serosal involvement. Rheumatol Int. 2011
Jul;31(7):979-80.
76: Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M. Serosal involvement
in adult-onset autoinflammatory disorders. Respiration. 2010;80(3):260-1; author
reply 262.
77: Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Laghi Pasini F, Galeazzi M.
Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor
receptor-associated periodic syndrome and response to etanercept therapy. Clin
Exp Rheumatol. 2010 Mar-Apr;28(2):290-1.
78: Cantarini L, Lucherini OM, Cimaz R, Rigante D, Baldari CT, Laghi Pasini F,
Galeazzi M. Typical and severe tumor necrosis factor receptor-associated periodic
syndrome in the absence of mutations in the TNFRSF1A gene: a case series.
Rheumatol Int. 2012 Dec;32(12):4015-8.
79: Rubbert-Roth A, Tak PP, Zerbini C, Tremblay JL, Carreño L, Armstrong G,
Collinson N, Shaw TM; MIRROR Trial Investigators. Efficacy and safety of various
repeat treatment dosing regimens of rituximab in patients with active rheumatoid
arthritis: results of a Phase III randomized study (MIRROR). Rheumatology
(Oxford). 2010 Sep;49(9):1683-93.
80: Filippou G, Mondelli M, Greco G, Bertoldi I, Frediani B, Galeazzi M, Giannini
F. Ulnar neuropathy at the elbow: how frequent is the idiopathic form? An
ultrasonographic study in a cohort of patients. Clin Exp Rheumatol. 2010
Jan-Feb;28(1):63-7.
81: Raffaeli W, Pari C, Corvetta A, Sarti D, Di Sabatino V, Biasi G, Galeazzi M.
Oxycodone/acetaminophen at low dosage: an alternative pain treatment for patients
with rheumatoid arthritis. J Opioid Manag. 2010 Jan-Feb;6(1):40-6.
82: Fioravanti A, Bellisai B, Capitani S, Manica P, Paolazzi G, Galeazzi M.
Phytothermotherapy: a possible complementary therapy for fibromyalgia patients.
Clin Exp Rheumatol. 2009 Sep-Oct;27(5 Suppl 56):S29-32.
83: De Stefano R, Frati E, Nargi F, Baldi C, Menza L, Hammoud M, Galeazzi M.
Comparison of combination therapies in the treatment of rheumatoid arthritis:
leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha. Clin Rheumatol.
2010 May;29(5):517-24.
84: Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S,
Laghi Pasini F, Capecchi PL, Sebastiani GD, Galeazzi M. Idiopathic recurrent
pericarditis refractory to colchicine treatment can reveal tumor necrosis factor
receptor-associated periodic syndrome. Int J Immunopathol Pharmacol. 2009
Oct-Dec;22(4):1051-8. 85: Cantarini L, Lucherini OM, Simonini G, Galeazzi M, Baldari CT,
Cimaz R. Systemic-onset juvenile idiopathic arthritis complicated by early onset
amyloidosis in a patient carrying a mutation in the MEFV gene. Rheumatol Int.
2012 Feb;32(2):465-7.
86: Bombardieri S, Ferraccioli G, Ferri C, Galeazzi M, Lapadula G, Cerinic MM,
Montecucco C, Triolo G, Trotta F, Valentini G. [Copernican revolution in the
therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
Reumatismo. 2009 Apr-Jun;61 Suppl 1:1-23. Italian.
87: Ginanneschi F, Filippou G, Reale F, Scarselli C, Galeazzi M, Rossi A.
Ultrasonographic and functional changes of the ulnar nerve at Guyon's canal after
carpal tunnel release. Clin Neurophysiol. 2010 Feb;121(2):208-13.
88: Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M. Innate versus
acquired immune response in the pathogenesis of recurrent idiopathic
pericarditis. Autoimmun Rev. 2010 Apr;9(6):436-40.
2011 Nov;11(1):76. Luca, Cantarini [corrected to Cantarini, Luca]; Massimo,
Imazio [corrected to Imazio, Massimo]; Antonio, Brucato [corrected to Brucato,
Antonio]; Maria, Lucherini Orso [corrected to Lucherini, Orso Maria]; Mauro,
Galeazzi [corrected to Galeazzi, Mauro].
89: Fulci V, Scappucci G, Sebastiani GD, Giannitti C, Franceschini D, Meloni F,
Colombo T, Citarella F, Barnaba V, Minisola G, Galeazzi M, Macino G. miR-223 is
overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum
Immunol. 2010 Feb;71(2):206-11.
90: Cantarini L, Lucherini OM, Galeazzi M, Fanti F, Simonini G, Baldari CT, Laghi
Pasini F, De Martino M, Cimaz R. Tumour necrosis factor receptor-associated
periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with
excellent response to etanercept treatment. Clin Exp Rheumatol. 2009
Sep-Oct;27(5):890-1.
91: Cantarini L, Volpi N, Lucherini OM, Giannini F, Galeazzi M. A case of amyloid
myopathy in a patient with familial Mediterranean fever. Clin Exp Rheumatol. 2009
Mar-Apr;27(2 Suppl 53):S106-7.
92: Fioravanti A, Iacoponi F, Bellisai B, Cantarini L, Galeazzi M. Short- and
long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil.
2010 Feb;89(2):125-32.
93: Sebastiani GD, Galeazzi M. Infection--genetics relationship in systemic lupus
erythematosus. Lupus. 2009 Nov;18(13):1169-75.
94: Spreafico A, Chellini F, Frediani B, Bernardini G, Niccolini S, Serchi T,
Collodel G, Paffetti A, Fossombroni V, Galeazzi M, Marcolongo R, Santucci A.
Biochemical investigation of the effects of human platelet releasates on human
articular chondrocytes. J Cell Biochem. 2009 Dec 1;108(5):1153-65.
95: Cetta F, Dhamo A, Malagnino G, Galeazzi M. Linking environmental particulate
matter with genetic alterations. Environ Health Perspect. 2009 Aug;117(8):A340;
author reply A340-1.
96: Sebastiani GD, Galeazzi M. Immunogenetic studies on systemic lupus
erythematosus. Lupus. 2009 Sep;18(10):878-83.
97: Garcia-Gonzalez E, Selvi E, Balistreri E, Lorenzini S, Maggio R, Natale MR,
Capecchi PL, Lazzerini PE, Bardelli M, Laghi-Pasini F, Galeazzi M. Cannabinoids
inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts. Rheumatology
(Oxford). 2009 Sep;48(9):1050-6.
98: Sánchez E, Palomino-Morales RJ, Ortego-Centeno N, Jiménez-Alonso J,
González-Gay MA, López-Nevot MA, Sánchez-Román J, de Ramón E, González-Escribano
MF, Pons-Estel BA, D'Alfonso S, Sebastiani GD; Italian collaborative group,
Alarcón-Riquelme ME, Martín J. Identification of a new putative functional IL18
gene variant through an association study in systemic lupus erythematosus. Hum
Mol Genet. 2009 Oct 1;18(19):3739-48.
99: Cantarini L, Fanti F, Galeazzi M, Martino S, Miracco C, Biagioli M, Dal
Canto N, Cimaz R. Efficacy of cyclosporine A treatment in relapsing febrile
lobular panniculitis associated with small vessel vasculitis. Rheumatol Int. 2010
Apr;30(6):797-9.
100: Cantarini L, Tinazzi I, Caramaschi P, Bellisai F, Brogna A, Galeazzi M.
Safety and efficacy of etanercept in children with juvenile-onset Behcets
disease. Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):551-5.
101: Giannitti C, Benucci M, Caporali R, Manganelli S, Bellisai F, Sebastiani GD,
Galeazzi M. Efficacy and safety of anti-TNF-alpha therapy combined with
cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C
virus infection. Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):543-6.
102: De Stefano R, Frati E, Volpi N, Galeazzi M. Sensory-motor axonal
multineuropathy during etanercept therapy for rheumatoid arthritis. Clin Exp
Rheumatol. 2009 Mar-Apr;27(2):381.
103: Cerboni B, Morozzi G, Galeazzi M, Bellisai F, Micheli V, Pompucci G, Sestini
S. Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and
systemic sclerosis. Hum Immunol. 2009 Jul;70(7):487-91.
104: Lu R, Vidal GS, Kelly JA, Delgado-Vega AM, Howard XK, Macwana SR, Dominguez
N, Klein W, Burrell C, Harley IT, Kaufman KM, Bruner GR, Moser KL, Gaffney PM,
Gilkeson GS, Wakeland EK, Li QZ, Langefeld CD, Marion MC, Divers J, Alarcón GS,
Brown EE, Kimberly RP, Edberg JC, Ramsey-Goldman R, Reveille JD, McGwin G Jr,
Vilá LM, Petri MA, Bae SC, Cho SK, Bang SY, Kim I, Choi CB, Martin J, Vyse TJ,
Merrill JT, Harley JB, Alarcón-Riquelme ME; BIOLUPUS and GENLES Multicenter
Collaborations, Nath SK, James JA, Guthridge JM. Genetic associations of LYN with
systemic lupus erythematosus. Genes Immun. 2009 Jul;10(5):397-403.
105: Leo G, Iuliano A, Spina D, Bellisai F, Fioravanti A, Galeazzi M.
Simultaneous pulmonary involvement, histologically proven, of sarcoidosis and
rheumatoid arthritis. Clin Exp Rheumatol. 2009 Jan-Feb;27(1):164.
106: Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sánchez E, Kelly JA, Li L, Liu Y,
Zhou J, Yan M, Ye Q, Liu S, Xie C, Zhou XJ, Chung SA, Pons-Estel B, Witte T, de
Ramón E, Bae SC, Barizzone N, Sebastiani GD, Merrill JT, Gregersen PK, Gilkeson
GG, Kimberly RP, Vyse TJ, Kim I, D'Alfonso S, Martin J, Harley JB, Criswell LA;
Profile Study Group; Italian Collaborative Group; German Collaborative Group;
Spanish Collaborative Group; Argentinian Collaborative Group; SLEGEN Consortium,
Wakeland EK, Alarcón-Riquelme ME, Mohan C. Kallikrein genes are associated with
lupus and glomerular basement membrane-specific antibody-induced nephritis in
mice and humans. J Clin Invest. 2009 Apr;119(4):911-23.
107: Lazzerini PE, Capecchi PL, Acampa M, Selvi E, Guideri F, Bisogno S, Rossi
PC, Galeazzi M, Pasini FL. Arrhythmogenic effects of anti-Ro/SSA antibodies on
the adult heart: more than expected? Autoimmun Rev. 2009 Sep;9(1):40-4.
108: Giannitti C, Bellisai F, Ferri C, Galeazzi M. Treatment strategies for a
patient with rheumatoid arthritis and hepatitis C. Expert Opin Pharmacother. 2009
Mar;10(4):579-87.
109: Fioravanti A, Fabbroni M, Cerase A, Galeazzi M. Treatment of erosive
osteoarthritis of the hands by intra-articular infliximab injections: a pilot
study. Rheumatol Int. 2009 Jun;29(8):961-5.
110: Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E,
Danieli MG, Abramovicz D, Blockmans D, Cauli A, Direskeneli H, Galeazzi M, Gül A,
Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J,
Depresseux G, Cosyns JP, Cervera R. The 10-year follow-up data of the Euro-Lupus
Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
Ann Rheum Dis. 2010 Jan;69(1):61-4.
111: Cantarini L, Volpi N, Carbotti P, Greco G, Aglianò M, Bellisai F, Giannini
F, Alessandrini C, Grasso G, Galeazzi M. Eosinophilia-associated muscle
disorders: an immunohistological study with tissue localisation of major basic
protein in distinct clinicopathological forms. J Clin Pathol. 2009
May;62(5):442-7.
112: Frati E, Maggio R, Gonzalez EG, Bardelli M, Galeazzi M. A whitish-creamy
synovial fluid. BMJ Case Rep. 2009;2009.
113: Pasquetti P, Morozzi G, Galeazzi M. Very low prevalence of anti-CCP
antibodies in rheumatoid factor-negative psoriatic polyarthritis. Rheumatology
(Oxford). 2009 Mar;48(3):315-6. doi: 10.1093/rheumatology/ken456.
114: Delgado-Vega AM, Abelson AK, Sánchez E, Witte T, D'Alfonso S, Galeazzi M,
Jiménez-Alonso J, Pons-Estel BA, Martin J, Alarcón-Riquelme ME. Replication of
the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus.
Genes Immun. 2009 Apr;10(3):248-53.
115: Volterrani L, Mazzei MA, Giordano N, Nuti R, Galeazzi M, Fioravanti A.
Magnetic resonance imaging in Tietze's syndrome. Clin Exp Rheumatol. 2008
Sep-Oct;26(5):848-53.
116: Cantarini L, Baldari CT, Rossi Paccani S, Lucherini OM, Laghi Pasini F,
Galeazzi M. Saturday night fever: bizarre recurrence of fever attacks in a
patient carrying a mutation in both the MEFV and TNFRSF1A genes. Clin Exp
Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S128-9; author reply S129.
117: Filippou G, Frediani B, Selvi E, Bertoldi I, Galeazzi M. Tendon involvement
in patients with ochronosis: an ultrasonographic study. Ann Rheum Dis. 2008
Dec;67(12):1785-6.
118: Orrú V, Tsai SJ, Rueda B, Fiorillo E, Stanford SM, Dasgupta J, Hartiala J,
Zhao L, Ortego-Centeno N, D'Alfonso S; Italian Collaborative Group, Arnett FC, Wu
H, Gonzalez-Gay MA, Tsao BP, Pons-Estel B, Alarcon-Riquelme ME, He Y, Zhang ZY,
Allayee H, Chen XS, Martin J, Bottini N. A loss-of-function variant of PTPN22 is
associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet. 2009
Feb 1;18(3):569-79. doi: 10.1093/hmg/ddn363.
119: Cantarini L, Brogna A, Fioravanti A, Galeazzi M. Henoch-Schönlein purpura
associated with pidotimod therapy. Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl
49):S152.
120: Spreafico A, Frediani B, Francucci CM, Capperucci C, Chellini F, Galeazzi M.
Role of apoptosis in osteoporosis induced by glucocorticoids. J Endocrinol
Invest. 2008 Jul;31(7 Suppl):22-7. Review.
121: Giannitti C, Morozzi G, D'Alfonso S, Bellisai F, Galeazzi M. [Viral genotype
and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV
infection]. Reumatismo. 2008 Jul-Sep;60(3):192-8. Italian.
122: Cantarini L, Fioravanti A, Brogna A, Capaccioli N, Galeazzi M. Atypical
juvenile polymyositis: usefulness of magnetic resonance imaging. J Clin
Rheumatol. 2008 Oct;14(5):309-10.
123: Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher
MM, Tincani A, Kontopoulou-Griva I, Galeazzi M, Bellisai F, Meroni PL, Derksen
RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F,
Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Piette
JC, Espinosa G, Bucciarelli S, Pisoni CN, Bertolaccini ML, Boffa MC, Hughes GR;
Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period:
a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2009 Sep;68(9):1428-32.
124: Selvi E, Lorenzini S, Garcia-Gonzalez E, Maggio R, Lazzerini PE, Capecchi
PL, Balistreri E, Spreafico A, Niccolini S, Pompella G, Natale MR, Guideri F,
Laghi Pasini F, Galeazzi M, Marcolongo R. Inhibitory effect of synthetic
cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
Clin Exp Rheumatol. 2008 Jul-Aug;26(4):574-81.
125: Lazzerini PE, Acampa M, Hammoud M, Maffei S, Capecchi PL, Selvi E, Bisogno
S, Guideri F, Galeazzi M, Pasini FL. Arrhythmic risk during acute infusion of
infliximab: a prospective, single-blind, placebo-controlled, crossover study in
patients with chronic arthritis. J Rheumatol. 2008 Oct;35(10):1958-65.
126: Galeazzi M, Giannitti C, Manganelli S, Benucci M, Scarpato S, Bazzani C,
Caporali R, Sebastiani GD. Treatment of rheumatic diseases in patients with HCV
and HIV infection. Autoimmun Rev. 2008 Dec;8(2):100-3.
127: Ferri C, Ferraccioli G, Ferrari D, Galeazzi M, Lapadula G, Montecucco C,
Triolo G, Valentini G, Valesini G; GISEA Group. Safety of anti-tumor necrosis
factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis
C virus infection. J Rheumatol. 2008 Oct;35(10):1944-9.
128: Egan CG, Caporali F, Garcia-Gonzalez E, Galeazzi M, Sorrentino V.
Endothelial progenitor cells and colony-forming units in rheumatoid arthritis:
association with clinical characteristics. Rheumatology (Oxford). 2008
Oct;47(10):1484-8.
129: Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G,
Menegatti E, Olivieri I, Puoti M, Palazzi C, Roccatello D, Vergani D,
Sarzi-Puttini P, Atzeni F. HCV infection: pathogenesis, clinical manifestations
and therapy. Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S39-47. Review.
130: Sebastiani GD, Morozzi G, Bellisai F, Fineschi I, Bacarelli MR, Simpatico A,
Font J, Cervera R, Houssiau F, Fernandez-Nebro A, De Ramon Garrido E, De Pità O,
Smolen J, Galeazzi M; ECAISLE. Anti-cofactor autoantibodies in systemic lupus
erythematosus: prevalence, clinical and HLA class II associations. Immunol
Invest. 2008;37(4):375-85.
131: Caporali F, Capecchi PL, Gamberucci A, Lazzerini PE, Pompella G, Natale M,
Lorenzini S, Selvi E, Galeazzi M, Laghi Pasini F. Human rheumatoid synoviocytes
express functional P2X7 receptors. J Mol Med (Berl). 2008 Aug;86(8):937-49.
132: Fioravanti A, Cantarini L, Burroni L, Mazzei MA, Volterrani L, Galeazzi M.
Efficacy of alendronate in the treatment of the SAPHO syndrome. J Clin Rheumatol.
2008 Jun;14(3):183-4.
133: Szyper-Kravitz M, Altman A, de Carvalho JF, Bellisai F, Galeazzi M, Eshet Y,
Shoenfeld Y. Coexistence of the antiphospholipid syndrome and abdominal aortic
aneurysm. Isr Med Assoc J. 2008 Jan;10(1):48-51.
134: Lazzerini PE, Capecchi PL, Guideri F, Acampa M, Selvi E, Bisogno S, Galeazzi
M, Laghi-Pasini F. Autoantibody-mediated cardiac arrhythmias: mechanisms and
clinical implications. Basic Res Cardiol. 2008 Jan;103(1):1-11.